• Home
  • News
  • Medicine supply notification: Shortage of disopyramide (Rythmodan Retard®) 250mg modified-release tablets and disopyramide (Rythmodan®) 100mg capsules

Medicine supply notification: Shortage of disopyramide (Rythmodan Retard®) 250mg modified-release tablets and disopyramide (Rythmodan®) 100mg capsules

NCL Wide
Add to Bookmarks Add to CPD
  • Tuesday, 23 July 2024

The Department of Health and Social Care (DHSC) has issued a medicine supply notification (MSN) for disopyramide (Rythmodan Retard®) 250mg modified-release tablets and disopyramide (Rythmodan®) 100mg capsules. There has been intermittent availability of stock and supply disruption is likely to persist until January 2025. 

Refer to the MSN/2024/075U for actions required and supporting information.

Download • PDF, 90.02 KB
Copy URL

NCL Medicine Supply Notification for disopyramide (Rythmodan Retard®) 250mg modified-release tablets and disopyramide (Rythmodan®) 100mg capsules

Expiry date: Monday, 23 September 2024